News feature: Costly US anticancer drugs pose problems for doctors and patients.
Where this comes from
- Record sourced from PubMed, PMID 18625596.
- Also identified by DOI 10.1136/bmj.a778 and PMC identifier 2483909.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
As the BMA calls for a royal commission to consider copayments for cancer drugs in the UK, <b>Fred Charatan</b> looks at the problem in the US
Medical subject headings
- Antineoplastic Agents
- Neoplasms